Tag Archives: Industrial Policy

Publications

25 Mar

Carapinha, J. (2000) Continuing Professional Development in Human Resource Management. Journal of Modern Pharmacy, 7 (10), 1-6. Carapinha, J. (2003) Rational Self-Medication within a South African Context. The Journal of Modern Pharmacy, February 2003. Carapinha, J. (2005) Ethical Decision Making in Managed Health Care. South African Pharmaceutical Journal, 72 (2). Carapinha, J. (2005) Evidence-Based Pharmacy Practice. […]

Loraine Hawkins – Competition Policy

16 Nov

Loraine shared her work on competition law to improve market efficiency with the ultimate aim of reducing medicine prices. While much of her presentation concerns government as regulator, little was said about government as market participant. For example, in certain circumstances, governments may wish to become a market player in the provision of pharmaceutical services […]

Biotech companies in emerging markets

20 Sep

As biotech companies in emerging markets move from imitation to innovation, they will reach a decision point – focus on local health demands or develop medicines for industrialized countries with larger markets. The authors suggest that biotech companies can meet both demands through an entrepreneurial model. However. the logic of the entrepreneurial model is such […]

Contract manufacturing can boost medicine exports to Tk 200b a year

25 Mar

Bangladesh can export drugs worth Tk200 billion a year if the local medicine makers upgrade their facilities to a level that’ll enable them to do contract manufacturing for foreign pharmaceuticals, experts said Sunday. Drug manufacturing is becoming costly in the highly regulated western market, prompting major pharmaceutical companies to contract out drug making to companies […]

Singapore Welcomes Scientific Talent

23 Mar

Asia has experienced rapid growth in the biomedical sciences and pharmaceutical fields. Within the last decade, Singapore has established itself as a global scientific powerhouse, attracting leading companies. The city-state has built up a reputation for biomedical sciences innovation in addition to being a global financial and business hub. Singapore’s biomedical sciences industry contributes 4.1% […]

S’pore’s biomedical output grew to $21b last year

18 Mar

SINGAPORE’S biomedical manufacturing output grew at a robust pace last year to reach $21 billion and employed 13,000 people, the Economic Development Board (EDB) said yesterday. According to Spring Singapore, last year’s production outpaced the previous year’s $19 billion and a value-add of $10.6 billion. Last year, the sector attracted cumulative capital of $1.2 billion […]

Pharmaceutical Costs, Technology Innovation, Opportunities & Reality

19 Feb

For an interesting and basic introduction to API manufacture, process innovation and associated costs, this article may be of interest. The full article is available here ************ Pharmaceutical Costs, Technology Innovation, Opportunities & Reality By Girish Malhotra, President, EPCOT International Pharmaceutical (branded or ethical, and generic) companies, like other companies, have the following code of […]

Producing Affordable Medicines

31 Oct

At a press conference in Pretoria on 15 January 2004 the Minister of Health of South Africa, Dr Manto Tshabalala-Msimang, informed the media of the contents of the draft Regulations Relating to a Transparent Pricing System for Medicines and Related Substances made in terms of the Medicines and Related Substances Control Amendment Act 90 of […]

Carapinha Logo